FcγRIIA H/R131 polymorphism, subclass-specific IgG anti- heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis

Blood

Volumn 89, Issue 2, 1997, Pages 370-375

  Arepally, Gowthami ^b   McKenzie, Steven E ^b   Jiang, Xiao Ming ^b   Poncz, Mortimer ^b   Cines, Douglas B ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FC RECEPTOR; HEPARIN; IMMUNOGLOBULIN G; THROMBOCYTE FACTOR 4;

AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0031033922     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.370     Document Type: Article

References (33)

1. Chong BH: Heparin-induced thrombocytopenia. Br J Haematol 89:431, 1995
2. Greinacher A: Antigen generation in heparin-associated thrombocytopenia: The nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 21:106, 1995
3. Warkentin TE, Kelton JG: Heparin-induced thrombocytopenia. Annu Rev Med 40:31, 1989
4. Boshkov LK, Warkentin TE, Hayward CP, Andrew M, Kelton JG: Heparin-induced thrombocytopenia and thrombosis: Clinical and laboratory studies. Br J Haematol 84:322, 1993
5. Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG: Heparin-induced thrombocytopenia: Laboratory studies. Blood 72:925, 1988
6. Chong BH, Fawaz I, Chesterman CN, Berndt MC: Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235, 1989
7. Anderson GP: Insights into heparin-induced thrombocytopenia. Br J Haematol 80:504, 1992
8. Warmerdam PA, Parren PW, Vlug A, Aarden LA, van de Winkel JG, Capel PJ: Polymorphism of the human Fc γ receptor II (CD32): Molecular basis and functional aspects. Immunobiology 185:175, 1992
9. 2 binding. J Immunol 147:1338, 1991
10. Parren PW, Warmerdam PA, Boeije LC, Arts J, Westerdaal NA, Vlug A, Capel PJ, Aarden LA, van de Winkel JG: On the interaction of IgG subclasses with the low affinity Fc α RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 90:1537, 1992
11. Brandt JT, Osborne JM, Chacko G, Anderson CL: The role of Fc-γ-RIIa phenotype in heparin-induced thrombocytopenia. Thromb Haemost 74:1564, 1995
12. Burgess JK, Lindeman R, Chesterman CN, Chong BH: Single amino acid mutation of Fc γ receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 91:761, 1995
13. Amiral J, Bridey F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, Meyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95, 1992 (letter)
14. Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D: Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases. Thromb Haemost 73:21, 1995
15. Greinacher A, Alban S, Dummel V, Franz G, Muellereckhardt C: Characterization of the structural requirements for a carbohydrate-based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia. Thromb Haemost 74:886, 1995
16. Amiral J, Marfaingkoka A, Wolf M, Alessi MC, Tardy B, Boyerneumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D: Presence of autoantibodies to interleukin-8 or neutrophil activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 88:410, 1996
17. Smith TF: IgG subclasses. Adv Pediatr 39:101, 1992
18. Winkler TH, Henschel TA, Kalies I, Baenkler HW, Skvaril F, Kalden JR: Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus. Clin Exp Immunol 72:434, 1988
19. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzleer EM, Gourley MF, Ramsey-Goldman R, Peterson MGE, Kimberly RP: FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97:1348, 1996
20. Anderson CL, Chacko GW, Osborne JM, Brandt JT: The Fc receptor for immunoglobulin G (Fc γ RII) on human platelets. Semin Thromb Hemost 21:1, 1995
21. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia. Blood 67:27, 1986
22. 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 104:648, 1995
23. Park KS, Rifat S, Eck H, Adachi K, Surrey S, Poncz M: Biologic and biochemic properties of recombinant platelet factor 4 demonstrate identity with the native protein. Blood 75:1290, 1990
24. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81, 1994
25. Amiral J, Peynaud-Debayle E, Wolf M, Bridey F, Vissac AM, Meyer D: Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients with unfractionated or low-molecular-weight heparin. Am J Hematol 52:90, 1996
26. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S: Construction of human gene libraries from small amounts of peripheral blood: Analysis of beta-like globin genes. Hemoglobin 6:27, 1982
27. Jiang XM, Arepally G, Poncz M, McKenzie SE: Rapid detection of the FcγRIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). J Immunol Methods 199:55, 1996
28. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz J, Hauck WW, Edie RN, Mannion JD: Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation (in press)
29. Visentin GP, Malik MI, Menden K, Aster RH: A prospective study of the formation of antibodies reactive with heparin: PF4 complexes in patients treated with heparin. Blood 84:80a, 1994 (abstr, suppl 1)
30. Schmitt BP, Adelman B: Heparin-associated thrombocytopenia: A critical review and pooled analysis. Am J Med Sci 305:208, 1993
31. Amiral J, Wolf M, Fischer A, Boyer-Neumann C, Vissac A, Meyer D: Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 92:954, 1996
32. Warkentin TE, Hayward CP, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG: Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84:3691, 1994
33. Cines DB, Tomaski A, Tannenbaum S: Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 316:581, 1987